Slaughter and May advised Nationwide Building Society on the deal. Nationwide Building Society completed its potential all-cash acquisition of Virgin Money UK PLC. The potential acquisition values...
You must be a Standard 1 Year member to access this content.
Bech-Bruun assisted Better Collective on the deal. Better Collective completed an accelerated bookbuild offering that raised gross proceeds of over DKK 1 billion at market, implying a...
You must be a Standard 1 Year member to access this content.
Paul Weiss Rifkind Wharton & Garrison advised Hornblower Group on the deal and Porter Hedges served as co-counsel, while Davis Polk & Wardwell advised Crestview Advisors,...
You must be a Standard 1 Year member to access this content.
Vinge advised Vimian Group AB on the offering. Vimian Group AB (publ) partly guaranteed rights issue which will provide Vimian with issue proceeds of SEK 1,633...
You must be a Standard 1 Year member to access this content.
Hogan Lovells advised Sircle Hospitality Group on the deal. SMG European Recovery SPAC SE entered into a definitive business combination agreement with Sircle Hospitality Group Ltd, the...
You must be a Standard 1 Year member to access this content.
Castrén & Snellman Attorneys advised BYG4Lab on the transaction. BYG4Lab, a portfolio company of the European growth buyout investor Keensight Capital, completed an acquisition of Finbiosoft Oy,...
You must be a Standard 1 Year member to access this content.
Davis Polk & Wardwell advised Lightyear Capital LLC on the transaction. Lightyear Capital LLC (“Lightyear”) has made an investment in Prime Pensions, LLC (“Prime Pensions”), one of...
You must be a Standard 1 Year member to access this content.
Paul Hastings LLP advised J.P. Morgan and Leerink Partners as co-lead placement agents, and Stifel co-placement agent, in the transaction. Lexeo Therapeutics, Inc. (Nasdaq: LXEO) has entered...
You must be a Standard 1 Year member to access this content.
Vinge advised Oncopeptides AB on the deal. Oncopeptides AB (publ) finalized a fully guaranteed rights issuance which will provide Oncopeptides with issue proceeds of approximately SEK...
You must be a Standard 1 Year member to access this content.
Clifford Chance advised amedes and the investor consortim comprising OMERS Infrastructure, Goldman Sachs Asset Management and AXA IM Alts on the acquisition of MVZ Laaff advised...
You must be a Standard 1 Year member to access this content.
Wigge advised Mofast AB on the deal. Mofast AB (Publ) completed a rights issuance, which is expected to provide the company with proceeds of approximately SEK...
You must be a Standard 1 Year member to access this content.
Gibson, Dunn & Crutcher represented Apogee Therapeutics, Inc. in the offering, and Cooley represented the underwriters. Apogee Therapeutics, Inc. (Nasdaq: APGE), a clinical-stage biotechnology company, announced the...
You must be a Standard 1 Year member to access this content.
